Adiponectin Levels in Obese and Non-obese Middle-aged African-American Women

Overview

Journal Obes Res Clin Pract

Publisher Elsevier

Specialty Endocrinology

Date 2013 Dec 20

PMID 24351429

Citations 6

Authors

Yves M Rolland

Matthew T Haren

Ping Patrick

William A Banks

Theodore K Malmstrom

Douglas K Miller

John E Morley

Affiliations

Soon will be listed here.

Abstract

Summary:

Context: Adiponectin levels in African-Americans are poorly described.

Objective: To assess predictors of serum adiponectin levels in obese and non-obese middle-aged African-American women.

Methods: Serum adiponectin, testosterone (T), free androgen index (FAI), estradiol, dehydroepiandrosterone sulfate (DHEAS), leptin, sex hormone binding globulin (SHBG), triglycerides and C-reactive protein (CRP) were measured in 142 obese and 102 non-obese, community-dwelling, African-American women in St. Louis, Missouri. Medical history, physical activity, anthropometry, medications and body composition were assessed.

Results: Adiponectin and SHBG levels were lower and leptin and CRP were higher in obese compared to non-obese women (P's < 0.01). Overall, log adiponectin was positively associated with age (R = 0.13) and log SHBG (R = 0.29), and inversely associated with anthropometric measures (R's = -0.17 to -0.36), serum androgens (R's = -0.21 to -0.23), log estradiol (R = -0.21), log leptin (R = -0.15), log triglycerides (R = -0.33) and log CRP (R = -0.29). Overall, multivariate modelling significantly predicted 32% of variation in adiponectin level; the most significant factors were WHR (β = -1.33), SHBG (β = 0.23) and triglycerides (β = -0.34). In non-obese women, the model predicted 27% of variation in adiponectin level; no individual factor was independently associated. In obese women, the model predicted 30% of variation in adiponectin level; the most significant factors were WHR (β = -1.49), triglycerides (β = -0.34) and history of stroke (β = -0.71).

Conclusions: Adiponectin level in African-American women is predicted by WHR, SHBG, and triglycerides; stroke history adds predictive value in obese women.

Citing Articles

Integrated neuromuscular training intervention applied in schools induces a higher increase in salivary high molecular weight adiponectin and a more favorable body mass index, cardiorespiratory fitness and muscle strength in children as compared to....

Vasileva F, Font-Llado R, Carreras-Badosa G, Cazorla-Gonzalez J, Lopez-Bermejo A, Prats-Puig A Front Public Health. 2024; 12:1337958.

PMID: 38756879 PMC: 11096568. DOI: 10.3389/fpubh.2024.1337958.

Periconceptional biomarkers for maternal obesity: a systematic review.

Hojeij B, Rousian M, Sinclair K, Dinnyes A, Steegers-Theunissen R, Schoenmakers S Rev Endocr Metab Disord. 2022; 24(2):139-175.

PMID: 36520252 PMC: 10023635. DOI: 10.1007/s11154-022-09762-5.

BMI Modifies Increased Mortality Risk of Post-PCI STEMI Patients with AKI.

Schvartz R, Lupu L, Frydman S, Banai S, Shacham Y, Gal-Oz A J Clin Med. 2022; 11(20).

PMID: 36294425 PMC: 9604849. DOI: 10.3390/jcm11206104.

Role of plasma adiponectin /C-reactive protein ratio in obesity and type 2 diabetes among African Americans.

Abraham P, Attipoe S, Kazman J, Zeno S, Poth M, Deuster P Afr Health Sci. 2017; 17(1):99-107.

PMID: 29026382 PMC: 5636261. DOI: 10.4314/ahs.v17i1.13.

The association between polycystic ovary syndrome, obesity, and the serum concentration of adipokines.

Behboudi-Gandevani S, Ramezani Tehrani F, Bidhendi Yarandi R, Noroozzadeh M, Hedayati M, Azizi F J Endocrinol Invest. 2017; 40(8):859-866.

PMID: 28332170 DOI: 10.1007/s40618-017-0650-x.

References

Bruun J, Lihn A, Verdich C, Pedersen S, Toubro S, Astrup A . Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003; 285(3):E527-33. DOI: 10.1152/ajpendo.00110.2003. View

Gillum R . Cardiovascular disease in the United States: an epidemiologic overview. Cardiovasc Clin. 1991; 21(3):3-16. View

Gui Y, Silha J, Murphy L . Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes Res. 2004; 12(9):1481-91. DOI: 10.1038/oby.2004.185. View

Gensini G, Comeglio M, Colella A . Classical risk factors and emerging elements in the risk profile for coronary artery disease. Eur Heart J. 1998; 19 Suppl A:A53-61. View

Sutton-Tyrrell K, Wildman R, Matthews K, Chae C, Lasley B, Brockwell S . Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation. 2005; 111(10):1242-9. DOI: 10.1161/01.CIR.0000157697.54255.CE. View

Vanhala M, Pitkajarvi T, Kumpusalo E, TAKALA J . Obesity type and clustering of insulin resistance-associated cardiovascular risk factors in middle-aged men and women. Int J Obes Relat Metab Disord. 1998; 22(4):369-74. DOI: 10.1038/sj.ijo.0800597. View

DEon T, Souza S, Aronovitz M, Obin M, Fried S, Greenberg A . Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem. 2005; 280(43):35983-91. DOI: 10.1074/jbc.M507339200. View

Xu A, Chan K, Hoo R, Wang Y, Tan K, Zhang J . Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005; 280(18):18073-80. DOI: 10.1074/jbc.M414231200. View

Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R . Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001; 507(2):142-6. DOI: 10.1016/s0014-5793(01)02960-x. View

10.

Pischon T, Girman C, Hotamisligil G, Rifai N, Hu F, Rimm E . Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14):1730-7. DOI: 10.1001/jama.291.14.1730. View

11.

Flegal K, Carroll M, Ogden C, Johnson C . Prevalence and trends in obesity among US adults, 1999-2000. JAMA. 2002; 288(14):1723-7. DOI: 10.1001/jama.288.14.1723. View

12.

Ferris W, Naran N, Crowther N, Rheeder P, Van der Merwe L, Chetty N . The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res. 2005; 37(11):695-701. DOI: 10.1055/s-2005-870580. View

13.

Sieminska L, Wojciechowska C, Niedziolka D, Marek B, Kos-Kudla B, Kajdaniuk D . Effect of postmenopause and hormone replacement therapy on serum adiponectin levels. Metabolism. 2005; 54(12):1610-4. DOI: 10.1016/j.metabol.2005.06.008. View

14.

Ducluzeau P, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M . Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88(8):3626-31. DOI: 10.1210/jc.2003-030219. View

15.

Miller D, Wolinsky F, Malmstrom T, Andresen E, Miller J . Inner city, middle-aged African Americans have excess frank and subclinical disability. J Gerontol A Biol Sci Med Sci. 2005; 60(2):207-12. DOI: 10.1093/gerona/60.2.207. View

16.

Schulze M, Rimm E, Shai I, Rifai N, Hu F . Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004; 27(7):1680-7. DOI: 10.2337/diacare.27.7.1680. View

17.

Sieminska L, Marek B, Kos-Kudla B, Niedziolka D, Kajdaniuk D, Nowak M . Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters. J Endocrinol Invest. 2005; 27(6):528-34. DOI: 10.1007/BF03347474. View

18.

Okosun I, Liao Y, Rotimi C, Prewitt T, Cooper R . Abdominal adiposity and clustering of multiple metabolic syndrome in White, Black and Hispanic americans. Ann Epidemiol. 2000; 10(5):263-70. DOI: 10.1016/s1047-2797(00)00045-4. View

19.

Soderberg S, Stegmayr B, Stenlund H, Sjostrom L, Agren A, Johansson L . Leptin, but not adiponectin, predicts stroke in males. J Intern Med. 2004; 256(2):128-36. DOI: 10.1111/j.1365-2796.2004.01351.x. View

20.

Brancati F, Kao W, Folsom A, Watson R, Szklo M . Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA. 2000; 283(17):2253-9. DOI: 10.1001/jama.283.17.2253. View